A citation-based method for searching scientific literature

Howard I Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N Sternberg, Kurt Miller, Ronald de Wit, Peter Mulders, Kim N Chi, Neal D Shore, Andrew J Armstrong, Thomas W Flaig, Aude Fléchon, Paul Mainwaring, Mark Fleming, John D Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S de Bono. N Engl J Med 2012
Times Cited: 3022



Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia, Ilsa Coleman, Marcin Cieslik, Matteo Benelli, Dan Robinson, Eliezer M Van Allen, Andrea Sboner, Tarcisio Fedrizzi, Juan Miguel Mosquera, Brian D Robinson, Navonil De Sarkar, Lakshmi P Kunju, Scott Tomlins, Yi Mi Wu, Daniel Nava Rodrigues, Massimo Loda, Anuradha Gopalan, Victor E Reuter, Colin C Pritchard, Joaquin Mateo, Diletta Bianchini, Susana Miranda, Suzanne Carreira, Pasquale Rescigno, Julie Filipenko, Jacob Vinson, Robert B Montgomery, Himisha Beltran, Elisabeth I Heath, Howard I Scher, Philip W Kantoff, Mary-Ellen Taplin, Nikolaus Schultz, Johann S deBono, Francesca Demichelis, Peter S Nelson, Mark A Rubin, Arul M Chinnaiyan, Charles L Sawyers. Proc Natl Acad Sci U S A 2019
Times Cited: 447




List of shared articles



Times cited

Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
Clara Martori, Lidia Sanchez-Moral, Tony Paul, Juan Carlos Pardo, Albert Font, Vicenç Ruiz de Porras, Maria-Rosa Sarrias. Cancers (Basel) 2022
3

ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Shaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, Maxim Kobelev, Olena Sivak, Takeshi Namekawa, Daksh Thaper, Sylvan C Baca, Matthew L Freedman, Adeleke Aguda,[...]. Nat Commun 2022
2

A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer.
Daniel Westaby, Maria de Los Dolores Fenor de La Maza, Alec Paschalis, Juan M Jimenez-Vacas, Jon Welti, Johann de Bono, Adam Sharp. Annu Rev Pharmacol Toxicol 2022
9

Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.
Andrea K Miyahira, Jelani C Zarif, Catherine C Coombs, Robert R Flavell, Joshua W Russo, Samir Zaidi, Di Zhao, Shuang G Zhao, Kenneth J Pienta, Howard R Soule. Prostate 2022
0

Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis.
Hyunho Han, Yan Wang, Josue Curto, Sreeharsha Gurrapu, Sara Laudato, Alekya Rumandla, Goutam Chakraborty, Xiaobo Wang, Hong Chen, Yan Jiang,[...]. Cell Rep 2022
2

A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer.
Yara Rodríguez, Kenji Unno, Mihai I Truica, Zachary R Chalmers, Young A Yoo, Rajita Vatapalli, Vinay Sagar, Jindan Yu, Barbara Lysy, Maha Hussain,[...]. Cancer Res 2022
0

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.
Yundong He, Weidong Xu, Yu-Tian Xiao, Haojie Huang, Di Gu, Shancheng Ren. Signal Transduct Target Ther 2022
2

Second generation androgen receptor antagonists and challenges in prostate cancer treatment.
Yanhua Chen, Qianqian Zhou, William Hankey, Xiaosheng Fang, Fuwen Yuan. Cell Death Dis 2022
0

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.
Michael P Kolinsky, Karen Y Niederhoffer, Edmond M Kwan, Sebastien J Hotte, Zineb Hamilou, Steven M Yip, Kim N Chi, Alexander W Wyatt, Fred Saad. Can Urol Assoc J 2022
1